packageInavolisib

inavolisib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Inavolisib is a PI3K inhibitor anticancer drug used to treat breast cancer. It is an approved medicine, with one product authorised in the European Union, and remains investigational for other uses.

Summary written by glm-5.3-flash from Wikidata Q76855355 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:inavolisib
ATC codes:L01EM06
DrugBank:DB15275
PubChem CID:124173720
Wikidata:Q76855355
formula:C18H19F2N5O4
molar mass:407.377 g/mol (PubChem CID 124173720)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown